We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Highlights Diagnostic Solutions for HPV & Cervical Cancer Screening, STIs and Vector-Borne Diseases

By LabMedica International staff writers
Posted on 05 Feb 2024
Print article
Image: BioPerfectus is attending Medlab Middle East 2024 (Photo courtesy of BioPerfectus)
Image: BioPerfectus is attending Medlab Middle East 2024 (Photo courtesy of BioPerfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is showcasing its range of diagnostics solutions for HPV and cervical cancer screening, sexually transmitted infections (STIs), and vector-borne diseases at Medlab Middle East 2024 that offer dependable, high-throughput, and cost-effective results.

BioPerfectus provides diagnostic solutions for STIs, including asymptomatic screening and clinical diagnosis. The key features of the company’s clinical STI testing technologies are adaptability and reliable outcomes. BioPerfectus’ products for STI asymptomatic screening, include the SAW-48 automated nucleic acid extraction workstation, the STC-96A PLUS Real-Time PCR system, nucleic acid extraction rapid kit, N. Gonorrhoeae / Chlamydia Trachomatis / U.urealyticum Real-Time PCR Kit, and STC auto interpretation software. In addition, BioPerfectus is highlighting its CE-marked PCR assays for STI clinical diagnostics such as Herpes Simplex Virus Real-Time PCR Kit, Herpes Simplex Virus Type I II Real-Time PCR Kit, Mycoplasma Genitalium Real-Time PCR Kit, Mycoplasma Hominis Real-Time PCR Kit, Trichomonas Vaginalis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit.

At Medlab Middle East 2024, BioPerfectus is showcasing its comprehensive range of diagnostic solutions essential for timely infectious disease control when outbreaks occur, including Vibrio Cholerae Real-Time PCR Kit, Monkeypox Virus Real-Time PCR Kit, Zika Virus / Dengue Virus / Chikungunya Virus Real-Time PCR Kit and Ebola Virus Real-Time PCR Kit. Visitors to the BioPerfectus booth at Medlab Middle East 2024 can experience the SAW-48 automated nucleic acid extraction workstation which is now lighter, smaller, and faster. Offering seamless workflow, it allows labs to go from the primary sample tube to a PCR ready-to-go tube in just one step, and say goodbye to time-consuming and complex processes.

Additionally, SAW-48 is compatible with various types of sample tubes and a diverse range of extraction and PCR reagents, making it the ideal choice for a wide spectrum of infectious disease diagnostic applications. In addition, BioPerfectus is highlighting the SSNP-2000B nucleic acid extraction system which integrates new technologies such as machine, electricity, and computer software to enable automatic nucleic acid extraction of 32 samples at one time. Alongside, BioPerfectus is presenting the STC-96A Plus Real-Time PCR system which is a more-than-ever flexible, efficient, and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. It allows laboratories to apply two different PCR assays on just one instrument with separate controlled programs.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.